Explore evidence

14 %In sub-Saharan Africa, only 14% of women aged 30 to 49 years have been screened for cervical cancer.

Kenyacancer du col de l'utéruspublished 2026BMC cancerPubMeddocument of 12 observations

3 per_317Among 317 women, invasive cervical cancer cases included HPV81 in 3/317 (0.9%).

Kenyacancer du col de l'utéruspublished 2021BioMed research internationalPubMeddocument of 9 observations

21.1 monthsThe median overall survival was 21.1 months among HIV-negative patients.

Kenyacancer du col de l'utérusobserved 2014–2023published 2026BMC cancerPubMeddocument of 16 observations

1,000 USDThe average lifetime cost per cervical cancer case is $1,000–$3,000.

Kenyacancer du col de l'utéruspublished 2025PloS onePubMeddocument of 3 observations

14 daysThe histopathology laboratory at Moi Teaching and Referral Hospital maintained an average 14-day turnaround time for cervical cancer pathology reports between 2018 and 2022.

Kenyacancer du col de l'utérusobserved 2018–2022published 2025BMC cancerPubMeddocument of 4 observations

43 %From 1st July 2022 to 30th June 2023, the number of facilities offering cervical cancer screening services increased from 23% to 43% of Fahari ya Jamii project-supported HIV clinics in Nairobi and Kajiado Counties.

Kenyacancer du col de l'utérusobserved 1st July 2022 to 30th June 2023published 2025BMC women's healthPubMeddocument of 8 observations

Cervical cancer remains a common and deadly cancer in areas without screening programs.

Kenyacancer du col de l'utéruspublished 2021JAMA network openPubMeddocument of 11 observations

38.7 %38.7% of women previously screened for cervical cancer underwent screening within the previous year.

Kenyacancer du col de l'utéruspublished 2025BMC women's healthPubMeddocument of 8 observations

3.8 %The overall cervical cancer screening positivity was 3.8% across the 19 facilities in Siaya and Busia counties of Kenya from September 2021 to September 2022.

Kenyacancer du col de l'utérusobserved September 2021 to September 2022published 2025JCO global oncologyPubMeddocument of 3 observations

184,000 casesAccelerated scale-up of 1-dose bivalent vaccine (2vHPV) would avert 184,000 cervical cancer cases compared with no vaccination.

Kenyacancer du col de l'utérusPubMeddocument of 6 observations

32.3 %Cervical cancer screening was reported in 32.3% of women living with HIV attending infant immunization clinics in Kenya.

Kenyacancer du col de l'utérusobserved 2018 and 2019published 2025BMC women's healthPubMeddocument of 8 observations

25 %Sub-Saharan Africa accounts for a quarter of global cervical cancer deaths.

Kenyacancer du col de l'utéruspublished 2026BMC cancerPubMeddocument of 12 observations

4 %4% of women previously screened for cervical cancer reported an abnormal screening result.

Kenyacancer du col de l'utéruspublished 2025BMC women's healthPubMeddocument of 8 observations

53.8 %Positive lymph nodes were the most common high-risk feature, occurring in 53.8% of people living with HIV and 40.0% of HIV-negative patients.

Kenyacancer du col de l'utérusobserved 2014–2023published 2026BMC cancerPubMeddocument of 16 observations

90 %Over 90% of cervical cancer-related deaths occur in low income countries.

Kenyacancer du col de l'utéruspublished 2022Frontiers in public healthPubMeddocument of 4 observations

0.16 hazard_ratioThose who underwent surgical management had 84% reduced hazard of mortality compared to those who were referred for other modes of care: HR: 0.16.

Kenyacancer du col de l'utéruspublished 2023BMC cancerPubMeddocument of 12 observations

6 timesWomen living with HIV are six times more likely to develop cervical cancer as compared to HIV-uninfected women in sub-Saharan Africa.

Kenyacancer du col de l'utéruspublished 2026BMC cancerPubMeddocument of 12 observations

42 %HPV vaccination could reduce the cervical cancer burden by 42–60 %.

Kenyacancer du col de l'utérus · infection à HPVpublished 2023VaccinePubMeddocument of 6 observations

5.2 %Of 632 patients, 5.2% received guideline-adherent cancer-directed therapy.

Kenyacancer du col de l'utéruspublished 2021The oncologisteurope_pmcdocument of 14 observationsDOI 10.1002/onco.13718

33.1 %The average relative survival from cervical cancer in the 11 countries was 33.1% at 5 years.

Kenyacancer du col de l'utérusobserved 2005 to 2015published 2020International journal of cancereurope_pmcdocument of 6 observations

Screening uptake improved in the intervention arm while declined in the control arm.

Kenyacancer du col de l'utéruspublished 2022Journal of cancer education : the official journal of the American Association for Cancer PubMeddocument of 3 observations

44 %Breast and cervical cancers accounted for 44% of all cancers in women in Nairobi during 2004–2008.

Kenyacancer du col de l'utérus · cancer du seinobserved 2004-2008published 2015International journal of cancereurope_pmcdocument of 9 observations

56 %Among women attending large HIV care and treatment programs across Kenya between June and September 2016, 1671 of 3007 (56%) reported ever being screened for cervical cancer.

Kenyacancer du col de l'utérusobserved June and September 2016published 2022International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument of 3 observations

275,000 deaths_per_yearCervical cancer claims the lives of 275,000 women each year.

Kenyacancer du col de l'utéruspublished 2014BMC public healtheurope_pmcdocument of 2 observations

85 %Approximately eighty five percent (211/247) of the study respondents were aware of cervical cancer.

Kenyacancer du col de l'utéruspublished 2016Journals & Books Hosting (International Knowledge Sharing Platform)OpenAlexdocument of 18 observations